MassMutual Private Wealth & Trust’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-114
Closed -$390 – 2454
2026
Q2
$390 Sell
114
-104
-48% -$346 ﹤0.01% 2307
2026
Q1
$780 Sell
218
-607
-74% -$2.41K ﹤0.01% 2177
2025
Q4
$2.9K Buy
825
+199
+32% +$681 ﹤0.01% 1886
2025
Q3
$2.04K Buy
626
+184
+42% +$580 ﹤0.01% 1977
2025
Q2
$1.08K Sell
442
-255
-37% -$1.29K ﹤0.01% 2104
2025
Q1
$4.65K Buy
697
+663
+1,950% +$6.55K ﹤0.01% 1637
2024
Q4
$427 Buy
+34
New +$512 ﹤0.01% 2167
2024
Q2
– Sell
-25
Closed -$674 – 2212
2024
Q1
$674 Buy
+25
New +$710 ﹤0.01% 1801

Other funds holding RCKT

MassMutual Private Wealth & Trust's RCKT Position: Q3 2026 in Review

MassMutual Private Wealth & Trust sold out of Rocket Pharmaceuticals (RCKT) in Q3 2026, closing a stake of 114 shares — an estimated $390 sold.

MassMutual Private Wealth & Trust first reported a position in RCKT in Q1 2024 and held it in 8 quarters. The position peaked at $4.65K in Q1 2025. 174 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • MassMutual Private Wealth & Trust reported no remaining Rocket Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 114 Rocket Pharmaceuticals shares in Q3 2026, an estimated $390.
  • MassMutual Private Wealth & Trust first reported a position in Rocket Pharmaceuticals in Q1 2024 and held it in 8 quarters.
  • MassMutual Private Wealth & Trust's Rocket Pharmaceuticals position peaked at $4.65K in Q1 2025.
  • 174 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.